Luminex to Launch New Multiplex Instruments,Seek FDA OK for Warfarin PGx Assay Next Year | GenomeWeb
This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
 
Luminex plans to launch a next-generation multiplex instrument next year that will be able to process more analytes and produce results twice as fast as its current Luminex 200 instrument, company officials said during the firm’s annual investors meeting in New York last week.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.